CD40L) was fused to SARS-CoV-2 spiking protein as a molecular adjuvant and targeting ligand and the fusion protein induced significant neutralizing antibodies, improved the immune response and prevented infection in the nasal turbinates and lungs [43]. This evidence concerns the gene CD40LG and infection.